Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Endometrial Hyperplasia × Metformin × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukoplakia, Oral 2 Glioblastoma 2 Erythroplasia 2 Carcinoma, Intraductal, Noninfiltrating 2 Urothelial Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Mouth Neoplasms 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Insulin Resistance 1 Hyperplasia 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Diabetes Mellitus 1 Carcinoma, Ovarian Epithelial 1 Brenner Tumor 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Pterocarpus marsupium 1 Metformin 1 Megestrol Acetate 1 Levonorgestrel 1 Everolimus 1 3,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡